Cited by 103Viral Infections and Immunology ResearchEvolution and Genetic DynamicsVirology and Viral Diseases

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Long-Term Circulation of Vaccine-Derived Poliovirus That Causes Paralytic Disease

Open access

Cherkasova, Elena A., Korotkova, Ekaterina A., Yakovenko, Maria L., Ivanova, Olga E., Eremeeva, Tatyana P., Chumakov, Konstantin M., Agol, Vadim I.·2002·Journal of Virology

DOI 10.1128/jvi.76.13.6791-6799.2002PMC PMC136293

Open this paper in CoChat — free account

Abstract

Successful implementation of the global poliomyelitis eradication program raises the problem of vaccination against poliomyelitis in the posteradication era. One of the options under consideration envisions completely stopping worldwide the use of the Sabin vaccine. This strategy is based on the assumption that the natural circulation of attenuated strains and their derivatives is strictly limited. Here, we report the characterization of a highly evolved derivative of the Sabin vaccine strain isolated in a case of paralytic poliomyelitis from a 7-month-old immunocompetent baby in an apparently adequately immunized population. Analysis of the genome of this isolate showed that it is a double (type 1-type 2-type 1) vaccine-derived recombinant. The number of mutations accumulated in both the type 1-derived and type 2-derived portions of the recombinant genome suggests that both had diverged from their vaccine predecessors ∼2 years before the onset of the illness. This fact, along with other recent observations, points to the possibility of long-term circulation of Sabin vaccine strain derivatives associated with an increase in their neurovirulence. Comparison of genomic sequences of this and other evolved vaccine-derived isolates reveals some general features of natural poliovirus evolution. They include a very high preponderance and nonrandom distribution of synonymous substitutions, conservation of secondary structures of important cis -acting elements of the genome, and an apparently adaptive character of most of the amino acid mutations, with only a few of them occurring in the antigenic determinants. Another interesting feature is a frequent occurrence of tripartite intertypic recombinants with either type 1 or type 3 homotypic genomic ends.

Integrity signals

Registry

Crossref · 10.1128/jvi.76.13.6791-6799.2002

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
Guex, N., & Peitsch, M. C. (1997) · Electrophoresis · doi:10.1002/elps.1150181505 · Cited by 11,312
RASMOL: biomolecular graphics for all
Sayle, R. A. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89080-5 · Cited by 2,587
Three-Dimensional Structure of Poliovirus at 2.9 Å Resolution
Hogle, J. M., Chow, M., & Filman, D. J. (1985) · Science · doi:10.1126/science.2994218 · Cited by 1,267
A new method for estimating synonymous and nonsynonymous rates of nucleotide substitution considering the relative likelihood of nucleotide and codon changes.
Li, W., Wu, C., & Luo, C. C. (1985) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040343 · Cited by 1,053
Origin and Evolution of Viruses
Holland, J. J., & Domingo, E. (1998) · Virus Genes · doi:10.1023/a:1007989407305 · Cited by 524
Fitness of RNA virus decreased by Muller’s ratchet
Chao, L. (1990) · Nature · doi:10.1038/348454a0 · Cited by 488
Complete nucleotide sequences of all three poliovirus serotype genomes
Toyoda, H., Kohara, M., Kataoka, Y., Suganuma, T., Omata, T., Imura, N., & Nomoto, A. (1984) · Journal of Molecular Biology · doi:10.1016/0022-2836(84)90084-6 · Cited by 415
WORLD HEALTH ASSEMBLY
Turner, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92377-5 · Cited by 388
New model for the secondary structure of the 5′ non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence
Skinner, M. A., Racaniello, V. R., Dunn, G., Cooper, J., Minor, P. D., & Almond, J. W. (1989) · Journal of Molecular Biology · doi:10.1016/0022-2836(89)90261-1 · Cited by 297
Identification of an RNA Hairpin in Poliovirus RNA That Serves as the Primary Template in the In Vitro Uridylylation of VPg
Paul, A. V., Rieder, E. A., Kim, D. W., BOOM, J. H. V., & Wimmer, E. (2000) · Journal of Virology · doi:10.1128/jvi.74.22.10359-10370.2000 · Cited by 289
Molecular Aspects of Picornavirus Infection and Detection
Semler, B. L., & Ehrenfeld, E. (1989) · Medical Entomology and Zoology · Cited by 259
Conserved structural domains in the 5′-untranslated region of picornaviral genomes: An analysis of the segment controlling translation and neurovirulence
Pilipenko, E. V., Blinov, V. M., Romanova, L. I., Sinyakov, A. N., Maslova, S. V., & Agol, V. I. (1989) · Virology · doi:10.1016/0042-6822(89)90259-6 · Cited by 259
Self-citation
Identification of a cis -Acting Replication Element within the Poliovirus Coding Region
Goodfellow, I., Chaudhry, Y., Richardson, A., Meredith, J. M., Almond, J. W., Barclay, W., & Evans, D. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4590-4600.2000 · Cited by 254
Transmissibility and Persistence of Oral Polio Vaccine Viruses: Implications for the Global Poliomyelitis Eradication Initiative
Fine, P. E. M., & Carneiro, I. A. M. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009924 · Cited by 247
Interaction of the poliovirus receptor with poliovirus
He, Y., Bowman, V. D., Mueller, S., Bator, C. M., Bella, J., Peng, X., Baker, T. S., Wimmer, E., Kuhn, R. J., & Rossmann, M. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.79 · Cited by 243
Molecular Tectonic Model of Virus Structural Transitions: the Putative Cell Entry States of Poliovirus
Belnap, D. M., Filman, D. J., Trus, B. L., Cheng, N., Booy, F. P., Conway, J. F., Curry, S., Hiremath, C. N., Tsang, S. K., Steven, A. C., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.3.1342-1354.2000 · Cited by 236
Interactions of Viral Protein 3CD and Poly(rC) Binding Protein with the 5′ Untranslated Region of the Poliovirus Genome
Gamarnik, A. V., & Andino, R. (2000) · Journal of Virology · doi:10.1128/jvi.74.5.2219-2226.2000 · Cited by 235
Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype
Kawamura, N., Kohara, M., Abe, S., Komatsu, T., Tago, K., Arita, M., & Nomoto, A. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1302-1309.1989 · Cited by 232
Recent changes to RasMol, recombining the variants
Bernstein, H. J., & Bernstein, H. J. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01606-6 · Cited by 230
Three-dimensional structure of poliovirus serotype 1 neutralizing determinants
Page, G. S., Mosser, A. G., Hogle, J. M., Filman, D. J., Rueckert, R. R., & Chow, M. (1988) · Journal of Virology · doi:10.1128/jvi.62.5.1781-1794.1988 · Cited by 222
Poly(rC) binding protein 2 binds to stem-loop IV of the poliovirus RNA 5' noncoding region: identification by automated liquid chromatography-tandem mass spectrometry.
Blyn, L., Swiderek, K., Richards, O. C., Stahl, D. C., Semler, B., & Ehrenfeld, E. (1996) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.93.20.11115 · Cited by 219
The molecular biology of poliovaccines
Minor, P. D. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-12-3065 · Cited by 217
Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient
Kew, O. M., Sutter, R. W., Nottay, B. K., McDonough, M. J., Prevots, D. R., Quick, L., & Pallansch, M. A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.10.2893-2899.1998 · Cited by 213
Antigenic and Molecular Evolution of the Vaccine Strain of Type 3 Poliovirus during the Period of Excretion by a Primary Vaccinee
Minor, P. D., John, A., Ferguson, M. A. J., & Icenogle, J. P. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-4-693 · Cited by 203
Genetic analysis of the attenuation phenotype of poliovirus type 1
Omata, T., Kohara, M., Kuge, S., Komatsu, T., Abe, S., Semler, B. L., Kameda, A., Itoh, H., Arita, M., & Wimmer, E. (1986) · Journal of Virology · doi:10.1128/jvi.58.2.348-358.1986 · Cited by 190
Genetic and Biochemical Studies of Poliovirus cis -Acting Replication Element cre in Relation to VPg Uridylylation
Rieder, E. A., Paul, A. V., Kim, D. W., BOOM, J. H. V., & Wimmer, E. (2000) · Journal of Virology · doi:10.1128/jvi.74.22.10371-10380.2000 · Cited by 167
Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y
Monica, N. L., & Racaniello, V. R. (1989) · Journal of Virology · doi:10.1128/jvi.63.5.2357-2360.1989 · Cited by 165
Evolution of the Sabin Strain of Type 3 Poliovirus in an Immunodeficient Patient during the Entire 637-Day Period of Virus Excretion
Martín, J., Dunn, G., Hull, R., Patel, V., & Minor, P. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3001-3010.2000 · Cited by 160
The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay
Balanant, J., Guillot, S., Candrea, A., Delpeyroux, F., & Crainic, R. (1991) · Virology · doi:10.1016/0042-6822(91)90434-d · Cited by 158
Determinants of Membrane Association for Poliovirus Protein 3AB
Towner, J. S., Ho, T. V., & Semler, B. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.26810 · Cited by 156
The Genomes of attenuated and virulent poliovirus strains differ in their in vitro translation efficiencies
Svitkin, Y. V., Maslova, S. V., & Agol, V. I. (1985) · Virology · doi:10.1016/0042-6822(85)90127-8 · Cited by 148
Self-citation
Polioviruses with Natural Recombinant Genomes Isolated from Vaccine-Associated Paralytic Poliomyelitis
Furlone, M., Guillot, S., Otelea, D., Balanant, J., Candrea, A., & Crainic, R. (1993) · Virology · doi:10.1006/viro.1993.1468 · Cited by 148 · cited 1×
“Poliovirus isolates from VAPP patients are very often represented by intertypic recombinants (23, 24 , 29, 43).”
Background
Detection and identification of vaccine-related polioviruses by the polymerase chain reaction
Yang, C.-F., De, L., Holloway, B. P., Pallansch, M. A., & Kew, O. M. (1991) · Virus Research · doi:10.1016/0168-1702(91)90107-7 · Cited by 144
Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine
Bouchard, M. J., Lam, D. H., & Racaniello, V. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4972-4978.1995 · Cited by 140
Evolution of Circulating Wild Poliovirus and of Vaccine-Derived Poliovirus in an Immunodeficient Patient: a Unifying Model
Gavrilin, G. V., Cherkasova, E. A., Lipskaya, G. Y., Kew, O. M., & Agol, V. I. (2000) · Journal of Virology · doi:10.1128/jvi.74.16.7381-7390.2000 · Cited by 138
Self-citation
Genomic Features of Intertypic Recombinant Sabin Poliovirus Strains Excreted by Primary Vaccinees
Cuervo, N. S., Guillot, S., Romanenkova, N., Combiescu, M., Aubert-Combiescu, A., Seghier, M., Caro, V., Crainic, R., & Delpeyroux, F. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.5740-5751.2001 · Cited by 136
Evolution of Poliovirus Type I during 5.5 Years of Prolonged Enteral Replication in an Immunodeficient Patient
Bellmunt, A., May, G., Zell, R., Pring-Åkerblom, P., Verhagen, W., & Heim, A. (1999) · Virology · doi:10.1006/viro.1999.0003 · Cited by 128 · cited 8×
“In principle, some synonymous substitutions may well affect biological properties of a virus (for a more detailed discussion of this point, see reference 26), and the occurrence of such silent mutations as C880U, U1141C, G1351A, U1798C, C2092U, and U2293C in another Sabin 1 derivative (5) may hint at their possible bi…”
BackgroundResultInfluential
Point mutations modify the response of poliovirus RNA to a translation initiation factor: A comparison of neurovirulent and attenuated strains
Svitkin, Y. V., Pestova, T. V., Maslova, S. V., & Agol, V. I. (1988) · Virology · doi:10.1016/0042-6822(88)90510-7 · Cited by 126
Self-citation
Comparative study of five methods for intratypic differentiation of polioviruses
van der Avoort, H. G., Hull, B. P., Hovi, T., Pallansch, M. A., Kew, O. M., Crainic, R., Wood, D. J., Mulders, M. N., & van Loon, A. M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.10.2562-2566.1995 · Cited by 122
Intertypic genomic rearrangements of poliovirus strains in vaccinees
Cammack, N. C., Phillips, A., Dunn, G., Patel, V., & Minor, P. D. (1988) · Virology · doi:10.1016/0042-6822(88)90113-4 · Cited by 111
Intertypic genomic rearrangements of poliovirus strains in vaccinees
CAMMACK, N., PHILLIPS, A., DUNN, G., PATEL, V, & MINOR, P. (1988) · Virology · doi:10.1016/s0042-6822(88)90113-4 · Cited by 111
High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis
Georgescu, M., Delpeyroux, F., Tardy-Panit, M., Balanant, J., Combiescu, M., Aubert-Combiescu, A., Guillot, S., & Crainic, R. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8089-8101.1994 · Cited by 109
Molecular and Antigenic Characterization of a Highly Evolved Derivative of the Type 2 Oral Poliovaccine Strain Isolated from Sewage in Israel
Shulman, L. M., Manor, Y., Handsher, R., Delpeyroux, F., McDonough, M., Halmut, T., Silberstein, I., Alfandari, J., Quay, J., Fisher, T., et al. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.10.3729-3734.2000 · Cited by 109
Stopping poliovirus vaccination after eradication: issues and challenges.
Wood, D. J., Sutter, R. W., & Dowdle, W. R. (2000) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862000000300010 · Cited by 107
Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature
Christodoulou, C., Colbère-Garapin, F., Macadam, A. J., Taffs, L. F., Marsden, S. A., Minor, P. D., & Horaud, F. (1990) · Journal of Virology · doi:10.1128/jvi.64.10.4922-4929.1990 · Cited by 106
Soluble receptor‐resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor.
Colston, E., & Racaniello, V. R. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06930.x · Cited by 104
Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine‐associated polio cases
Lipskaya, G. Y., Muzychenko, A. R., Kutitova, O. K., Maslova, S. V., Equestre, M., Drozdov, S. G., Bercoff, R. P., & Agol, V. I. (1991) · Journal of Medical Virology · doi:10.1002/jmv.1890350415 · Cited by 97
Self-citation
Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis
Georgescu, M. M., Balanant, J., Macadam, A., Otelea, D., Combiescu, M., Combiescu, A. A., Crainic, R., & Delpeyroux, F. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7758-7768.1997 · Cited by 83
Studies on the recombination between RNA genomes of poliovirus: The primary structure and nonrandom distribution of crossover regions in the genomes of intertypic poliovirus recombinants
Tolskaya, E. A., Romanova, L. I., Blinov, V. M., Viktorova, E. G., Sinyakov, A. N., Kolesnikova, M. S., & Agol, V. I. (1987) · Virology · doi:10.1016/0042-6822(87)90170-x · Cited by 81
Self-citation
Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition
Colston, E. M., & Racaniello, V. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4823-4829.1995 · Cited by 75
The Polio Eradication Effort: Should Vaccine Eradication Be Next?
Dove, A. W., & Racaniello, V. R. (1997) · Science · doi:10.1126/science.277.5327.779 · Cited by 71
Recombination and Other Genomic Rearrangements in Picornaviruses
Agol, V. I. (1997) · Seminars in Virology · doi:10.1006/smvy.1997.0112 · Cited by 66
Self-citation
A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice
Tardy-Panit, M., Blondel, B., Martin, A., Tekaia, F., Horaud, F., & Delpeyroux, F. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4630-4638.1993 · Cited by 64
Viral Quasispecies and Fitness Variations
Domingo, E., Escarmı́s, C., Menéndez‐Arias, L., & Holland, J. J. (1999) · Elsevier eBooks · doi:10.1016/b978-012220360-2/50008-8 · Cited by 63
A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating
Tatem, J. M., Weeks-Levy, C., Georgiu, A. F., Dimichele, S. J., Gorgacz, E. J., Racaniello, V. R., Cano, F. R., & Mento, S. J. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.3194-3197.1992 · Cited by 62
Disease eradication as a public health strategy: a case study of poliomyelitis eradication.
Aylward, R. B., Hull, H. F., Cochi, S. L., Sutter, R. W., Olivé, J. M., & Melgaard, B. (2000) · Europe PMC (PubMed Central) · Cited by 60
Coupled mutations in the 5'-untranslated region of the Sabin poliovirus strains during in vivo passages: structural and functional implications
Muzychenko, A. R., Lipskaya, G. Y., Maslova, S. V., Svitkin, Y. V., Pilipenko, E. V., Nottay, B. K., Kew, O. M., & Agol, V. I. (1991) · Virus Research · doi:10.1016/0168-1702(91)90002-d · Cited by 45
Self-citation
Alteration in oligonucleotide fingerprint patterns of the viral genome in poliovirus type 2 isolated from paralytic patients
Yoneyama, T., Hagiwara, A., Hara, M., & Shimojo, H. (1982) · Infection and Immunity · doi:10.1128/iai.37.1.46-53.1982 · Cited by 44
Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients
Li, J., Zhang, L. B., Yoneyama, T., Yoshida, H., Shimizu, H., Yoshii, K., Hara, M., Nomura, T., Yoshikura, H., Miyamura, T., et al. (1996) · Archives of Virology · doi:10.1007/bf01718608 · Cited by 40
A Sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site 1.
Mulders, M. N., Reimerink, J. H. J., Stenvik, M., Alàeddínoğlu, I., van der Avoort, H. G. A. M., Hovi, T., & Koopmans, M. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-4-907 · Cited by 38
Assessment of Poliovirus Eradication in Japan: Genomic Analysis of Polioviruses Isolated from River Water and Sewage in Toyama Prefecture
Matsuura, K., Ishikura, M., Yoshida, H., Nakayama, T., Hasegawa, S., Ando, S., Horie, H., Miyamura, T., & Kitamura, T. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.11.5087-5091.2000 · Cited by 37
Circulation of a Type 2 Vaccine-Derived Poliovirus--Egypt, 1982-1993
(2001) · JAMA · doi:10.1001/jama.285.9.1148 · Cited by 34
Genetic Stability and Mutant Selection in Sabin 2 Strain of Oral Poliovirus Vaccine Grown under Different Cell Culture Conditions
Taffs, R. E., Chumakov, K. M., Rezapkin, G. V., Lu, Z., Douthitt, M., Dragunsky, E. M., & Levenbook, I. S. (1995) · Virology · doi:10.1006/viro.1995.1268 · Cited by 33
Self-citation
Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses.
Oţelea, D., Guillot, S., Furione, M., Aubert-Combiescu, A., Balanant, J., Candrea, A., & Crainic, R. (1993) · PubMed · Cited by 33
Microevolution of Type 3 Sabin Strain of Poliovirus in Cell Cultures and Its Implications for Oral Poliovirus Vaccine Quality Control
Rezapkin, G. V., Norwood, L. P., Taffs, R. E., Dragunsky, E. M., Levenbook, I. S., & Chumakov, K. M. (1995) · Virology · doi:10.1006/viro.1995.1420 · Cited by 32
Self-citation
Ending Polio Immunization
Hull, H. F., & Aylward, R. B. (1997) · Science · doi:10.1126/science.277.5327.780 · Cited by 31
Vaccine-associated cases of poliomyelitis over a 30 year period in East Germany
Driesel, G., Diedrich, S., Künkel, U., & Schreier, E. (1995) · European Journal of Epidemiology · doi:10.1007/bf01720298 · Cited by 25
Acute Flaccid Paralysis Associated With Circulating Vaccine-Derived Poliovirus—Philippines, 2001
(2002) · JAMA · doi:10.1001/jama.287.3.311-jwr0116-2-1 · Cited by 25
Update: Outbreak of Poliomyelitis—Dominican Republic and Haiti, 2000-2001
(2001) · JAMA · doi:10.1001/jama.286.22.2802 · Cited by 24
Evidence for a complex structure of neutralization antigenic site I of poliovirus type 1 Mahoney
Wiegers, K. J., Uhlig, H., & Dernick, R. (1988) · Journal of Virology · doi:10.1128/jvi.62.5.1845-1848.1988 · Cited by 21
Random selection: a model for poliovirus infection of the central nervous system.
Georgescu, M. M., Ozden, S., Crainic, R., & Balanant, J. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-8-1819 · Cited by 21
Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil.
Friedrich, F., Ef, D.-S., & Hg, S. (1996) · PubMed · Cited by 21
Genetic Diversity and Rapid Evolution of Poliovirus in Human Hosts
Kinnunen, L., Pöyry, T. A. A., & Hovi, T. (1992) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-77011-1_4 · Cited by 20
It is too early to stop polio vaccination.
Racaniello, V. R. (2000) · PubMed · Cited by 16
Some problems of molecular biology of poliovirus infection relevant to pathogenesis, viral spread and evolution.
Agol, V. I., Belov, G. A., Cherkasova, E. A., Gavrilin, G. V., Kolesnikova, M. S., Romanova, L. I., & Tolskaya, E. A. (2001) · PubMed · Cited by 6
Self-citation
INTRODUCTION
Mayo, M. A. (1997) · Seminars in Virology · doi:10.1006/smvy.1997.0100 · Cited by 6

Research works printed but not linked: 2

Kimman, T. F., M. P. Koopmans, and H. G. van der Avoort. 1998. Ending polio immunization. Science 279 : 788-789.
King, A. M. Q. 1988. Genetic recombination in positive strand RNA viruses, p. 149-165. In E. Domingo, J. J. Holland, and P. Ahlquist (ed.), RNA Genetics. CRC Press, Inc., Boca Raton, Fla.

Sorted by citations

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703
Pathogen recognition and development of particulate vaccines: Does size matter?
Xiang, S. D., Scholzen, A., Minigo, G., David, C. T., Apostolopoulos, V., Mottram, P. L., & Plebanski, M. (2006) · Methods · doi:10.1016/j.ymeth.2006.05.016 · Cited by 602
Immunity in response to particulate antigen-delivery systems
Storni, T., Kündig, T. M., Senti, G., & Johansen, P. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.008 · Cited by 315
Evidence for Frequent Recombination within SpeciesHuman Enterovirus BBased on Complete Genomic Sequences of All Thirty-Seven Serotypes
Oberste, M. S., Maher, K., & Pallansch, M. A. (2003) · Journal of Virology · doi:10.1128/jvi.78.2.855-867.2004 · Cited by 258
Circulating vaccine-derived polioviruses: current state of knowledge.
Kew, O. M., Wright, P. F., Agol, V. I., Delpeyroux, F., Shimizu, H., Nathanson, N., & Pallansch, M. A. (2004) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862004000100006 · Cited by 257
Self-citation

See all 103

Authors: Cherkasova, E. A., Korotkova, E. A., Yakovenko, M. L., Ivanova, O. E., Eremeeva, T. P., Chumakov, K. M., & Agol, V. I.
Affiliations: Center for Biologics Evaluation and Research (US)
Lomonosov Moscow State University (RU)
Chumakov Institute of Poliomyelitis and Viral Encephalitides (RU)
ORCID: Cherkasova, Elena A.
Ivanova, Olga E.
Eremeeva, Tatyana P.
Agol, Vadim I.
Venue: Journal of Virology
Publisher: American Society for Microbiology
Published: 2002-07
Volume: 76
Issue: 13
Pages: 6791-6799
ISSN: 0022-538X (ISSN-L)
1098-5514
DOI: 10.1128/jvi.76.13.6791-6799.2002
PMC: PMC136293
OpenAlex: W2141343601
Cited by: 103
References: 76
Citations by year: 2026: 3 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 2 · 2016: 5 · 2015: 1 · 2014: 2 · 2013: 3 · 2012: 6
FWCI: 6.11
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Journal of Virology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Defense Advanced Research Projects Agency
Topics: Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
Keywords: vaccine-derived poliovirus, paralytic poliomyelitis, Sabin vaccine strains, poliovirus evolution, intertypic recombination, neurovirulence, synonymous substitutions, cis-regulatory elements, adaptive mutation, antigenic determinants
MeSH terms: Base Sequence, Female, Humans, Infant, Molecular Sequence Data, Mutation, Poliomyelitis, Poliovirus Vaccine, Oral, Genome, Viral, Sequence Analysis, DNA, Poliovirus, Evolution, Molecular, Amino Acid Substitution, 5' Untranslated Regions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Long-Term Circulation of Vaccine-Derived Poliovirus That Causes Paralytic Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks